Publication date


Middeldorp, M., Veldhuijzen, I.K., Vennema, H., Suijkerbuijk, A.W.M., Hooiveld, M., Pijnacker, R., Bruijning-Verhagen, P., Melker, H.E. de. Rotavirus. In: T.M. Schurink-van 't Klooster, H.E. de Melker. The National Immunisation Programme in the Netherlands, 2019-2020. Bilthoven: RIVM p. 7.
Download the PDF
Key points
- The number of rotavirus detections in 2019 was slightly lower than in 2018. In 2020 up to May, fewer rotavirus detections have been reported compared to the same period in 2019. A marked reduction in the number of rotavirus detections has been observed as of March 2020, i.e. following implementation of Dutch COVID-19 response measures.
- G9P8 and G3P8 were the most prevalent genotypes in 2019.
- The Ministry of Health, Welfare and Sport has decided to cancel the implementation of rotavirus vaccination for high-risk groups in the National Immunisation Programme. In the RIVAR study, lower vaccine-effectiveness estimates were unexpectedly found for high-risk infants. The Ministry requested a new recommendation from the Dutch Health Council.